These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 29172759)

  • 21. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
    Lee SY; Cho HJ
    Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy.
    Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R
    Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
    Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
    Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
    Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
    Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.
    Dinakar YH; Rajana N; Kumari NU; Jain V; Mehra NK
    AAPS PharmSciTech; 2023 Dec; 24(8):258. PubMed ID: 38097825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
    Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R
    Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer.
    Hu H; Zhang Y; Ji W; Mei H; Wu T; He Z; Wang K; Shi C
    J Microencapsul; 2022 Jan; 39(1):25-36. PubMed ID: 34859741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer.
    Nguyen TTK; Woo SM; Seo SU; Banstola A; Kim H; Duwa R; Vu ATT; Hong IS; Kwon TK; Yook S
    Biomaterials; 2025 Jan; 312():122733. PubMed ID: 39106819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
    Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
    J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of biodegradable nanoparticles as antigen delivery system.
    Petrizzo A; Conte C; Tagliamonte M; Napolitano M; Bifulco K; Carriero V; De Stradis A; Tornesello ML; Buonaguro FM; Quaglia F; Buonaguro L
    J Exp Clin Cancer Res; 2015 Oct; 34():114. PubMed ID: 26444005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma.
    Wang K; Kievit FM; Jeon M; Silber JR; Ellenbogen RG; Zhang M
    Adv Healthc Mater; 2015 Dec; 4(17):2719-26. PubMed ID: 26498165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery.
    Lin WJ; Lee WC
    Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.
    Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B
    Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.